PORT-9

N/A

Report date: 2022/07/12 13:48:41
NME

Base Information

Drug NamePORT-9
Drug Alias NameTT-3PORT-9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2b receptor antagonists
TargetsAdenosine A2b receptor
Therapy Area/IndicationsColorectal NeoplasmsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesTarus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A